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ABSTRACT 
Ultrasound imaging is a powerful tool in medicine because of the millisecond temporal 
resolution and sub-millimeter spatial resolution of acoustic imaging. However, the current 
generation of acoustic contrast agents is primarily limited to vascular targets due to their 
large size. Nano-size particles have the potential to be used as a contrast agent for 
ultrasound molecular imaging. Silica-based nanoparticles have shown promise here, 
however their slow degradation rate may limit their applications as a contrast agent. 
Phosphate-based glasses are an attractive alternative with controllable degradation rate and 
easily metabolized degradation components in the body. In this study, biodegradable P2O5-
CaO-Na2O phosphate-based glass nanospheres (PGNs) were synthesized and characterized 
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as contrast agents for ultrasound imaging. The structure of the PGNs was characterised 
using scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), 
X-ray diffraction (XRD), 31P nuclear magnetic resonance (31P MAS-NMR), and Fourier 
transform infrared (FTIR) spectroscopy. The SEM images indicated a spherical shape with 
a diameter size range of 200-500 nm. The XRD, 31P NMR and FTIR results revealed the 
amorphous and glassy nature of PGNs that consisted of mainly Q1 and Q2 phosphate units. 
We used this contrast to label mesenchymal stem cells and determined in vitro and in vivo 
detection limits of 5 and 9 µg/mL, respectively. Cell counts down to 4000 could be 
measured with ultrasound imaging with no cytoxicity at doses needed for imaging. 
Importantly, ion release studies confirmed these PGNs biodegrade into aqueous media 
with degradation products that can be easily metabolized in the body. 
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Ultrasound imaging is a real time, low cost, non-ionizing and effective imaging tool, yet 
remains primarily an anatomic tool versus positron emission tomography (PET) or 
bioluminescence. While ultrasound contrast agents can increase the signal specificity for 
molecular imaging by increasing backscattered echoes from the target site, the current 
generation of microbubbles are too large to be used outside of the vasculature or inside 
specific cells of interest.1-4 Microbubbles were first introduced as a contrast agent in 1968 
by injecting agitated saline into the ascending aorta and cardiac chambers during 
echocardiographic examination.5 Strong echoes were produced within the heart, due to the 
acoustic mismatch between free air microbubbles in the saline and the surrounding blood. 
However, microbubbles produced by agitation are both large and unstable and diffusing 
into solution in a short period of time.  
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To overcome these limitations encapsulated gas bubbles were invented, however these 
microbubbles are unstable in circulation even with polyethylene glycol surface treatment.6-
8 Furthermore, microbubbles require a careful choice of ultrasound frequency because 
microbubbles burst at low frequencies that can result in local microvasculature rupture and 
hemolysis.9 While nanobubbles have made important improvements in this area, a 
complete solution has remained elusive.10-12  
One alternative is solid nanoparticles that have utility as backscatter contrast agents for 
ultrasound molecular imaging.13-15 These solid particles have been used to image stem 
cells in cardiac regenerative medicine or to image cell surface proteins in cancer cells.13, 14 
However, the material properties of these agents are critical. They must have acoustic 
impedance capable of strongly and stably backscattering incident acoustic energy, but also 
be metabolized and removed safely from the body shortly thereafter. Finally, the particles 
must be small enough to extravasate from tumor vasculature due to the enhanced 
permeation and retention effect or be phagocytosed by cells when growing in culture. 
While silica-based nanoparticles have shown promise here,16-18 phosphate-based glasses 
are an attractive alternative because they offer a controllable degradation rate by varying 
their chemical compositions and which give rise to easily metabolized degradation 
components in the body.19-21 
Previous approaches to preparing ternary phosphate-based glasses in the P2O5-CaO-Na2O 
system via a sol-gel synthesis method have focused on preparing bulk sol-gel glasses.22, 23 
However, because of the slow reaction of the phosphate precursors, the reaction times 
were long. In addition, subsequent high drying temperatures made it difficult to prepare 
bulk glasses suitable for biomedical applications.  
Here we report a new simplified sol-gel synthesis method to prepare a ternary P2O5-CaO-
Na2O glass system at low temperature with subsequent electrospraying to obtain nano-
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spherical glasses. The PGNs were characterized by SEM, EDX, XRD, 31P MAS-NMR, 
and FTIR spectroscopy as well as in vitro and in vivo ultrasound imaging. Biodegradation 
was then monitored via inductively coupled plasma mass spectroscopy (ICP-MS) to 
measure phosphorus, calcium, and sodium ion release into aqueous media. We then used 
these tools to labelled mesenchymal stem cells (MSCs) and studied the effect the contrast 
agents had on cell viability as well as the signal increases generated by the PGNs. To the 
best of our knowledge, this is the first report of sol-gel synthesis and electrospraying to 
prepare biodegradable PGNs at low temperature and the first use of such a system for 
imaging purposes.  
RESULTS 
SEM and EDX 
We successfully synthesized the nanoparticles with electrospraying technique (Fig. 1A). 
The shape and particle size of the particles were identified by SEM images. Figure 1B,C 
show nano-spherical particles and measurement of the particle size for more than 100 
particles confirmed more than 80% of the particles had a diameter size distribution of 200-
500 nm with a mean diameter size of 320 nm. The EDX results were also converted to 
mol% to allow the comparison to be made with the theoretical composition and reported in 
Table 1. The results show a reduction of around 12.5 mol% P2O5 content from the 
theoretical values, with a concomitant increase in the percentage content of the other 
oxides to compensate. This reduction can be related to the unreacted phosphorus that is 
lost during heating stages. 
XRD and 31P MAS-NMR 
The XRD pattern of the PGNs was free of any detectable crystalline phase (Fig. 2A). Only 
two broad peaks at 2θ values between 20-50° were observed. This confirmed the 
amorphous nature of PGNs. 
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Figure 2B shows the solid-state 31P MAS NMR spectrum from PGNs. The peak at 1.7 
ppm corresponds to the presence of Q0 phosphate units that can be related to unreacted 
phosphorus in the structure 23. The peaks with the chemical shifts at -8.3 and -21.9 ppm are 
assigned to Q1 and Q2 units, respectively (Table 2).23, 24	  	  
FTIR 
Figure 3 presents FTIR data for PGNs that allow assignment according to the previous 
FTIR studies on phosphate-based glasses.22, 25-29 The peak at 730 cm-1 can be assigned to 
symmetrical stretching ʋs ( P ̶ O ̶ P) mode, while the peak at 900 cm-1 can be assigned to 
asymmetrical stretching ʋas (P ̶ O ̶ P) mode (Q2 phosphate units). The peaks at 1100 and 
1235 cm-1 are also assigned to asymmetrical ʋas (PO3)-2 and ʋas (PO2) modes that can be 
related to Q1 and Q2 phosphate units respectively. 
Ion release study 
The concentration of phosphorus, calcium, and sodium released into solution at different 
time points are presented in Figure 4. It can be seen that the highest rate of ion release 
occurs within the first 4 hours over the entire study period for all the elements. It should be 
noted that there is a small difference between the obtained data from EDX and ICP that 
can be related to the dissolution behavior of phosphorus that requires the hydrolysis of P-
O-P bonds prior to release, whereas other elements may be released via diffusion.30 
Cytotoxicity study  
We measured the cell viability with MTS and studied whether reactive oxygen species 
were generated with DCFDA (Fig. 5). MSCs were used for both applications because of 
the utility of ultrasound in cardiac stem cell therapy.14, 31 The cells were positive for 
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CD105, CD166, CD29, CD44, CD14, CD34, and CD45 and were below passage number 
5.  
The DCFDA assay was first validated with both positive and negative controls. The 
negative control used wells with no cells plated, and the positive control was wells with 
MSCs stimulated by 10% hydrogen peroxide. The negative control had a fluorescence 
value of 297 ± 76 which is attributed to auto-fluorescence from the plastic well plate. The 
MSCs in media with neither PGNs nor H2O2 had a value of 869 ± 118. The H2O2 positive 
control validated the assay and was 2.2-fold higher than the control cells. The experiments 
with PGNs added to the MSCs showed no increase in DCFDA signal except at 1000 
µg/mL. Here, the signal increased 1.6-fold to 1372 ± 41—a value that was significant at 
p<0.0001 versus the 0 µg/mL control. All other PGNs concentrations had p values above 
0.05 indicating no generation of ROS (Fig. 5A). 
We also used the MTS assay to measure any effects on cell viability and used two 
fractions of PGNs; freshly dissolved PGNs in PBS (Fig. 5B, Fresh) and PGNs that had 
been in PBS overnight (Fig. 5B, Degraded). In both cases, cells were treated with 
increasing concentrations of PGNs. The positive control was the known cytotoxic agent 
CTAB.  Cells without stimulation had an optical density at 490 nm of 0.85 ± 0.06 for the 
fresh sample and 0.90 ± 0.05 for the degraded sample. No concentrations had a statistically 
significant change to baseline except the positive control, which suppressed the signal 4.3-
fold and 4.1-fold for the fresh and degraded samples, respectively. 	  
In vitro ultrasound imaging 
We tested the ability of the PGNs to backscatter acoustic energy with phantoms. Inclusions 
contain increasing concentrations of PGNs were added to the agarose support and imaged 
at 40 MHz (Fig. 6). In Figure 6A, the echogenicity of a 0 mg/mL water control is seen. 
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The outline of the well can be seen clearly due to the presence of air bubbles that became 
trapped on the side of the well (green dashed lines). A much more intense signal is seen 
when an identical well is loaded with 1 mg/mL PGNs (Fig. 6B). The mean intensity of this 
image and at least three replicate images was measured to be 81.5 ± 1.3 a.u. This value and 
the value determined for the other concentrations of PGNs is plotted in Figure 6C. Using 
the best fit line (R2>0.99) and the background value of 5.3 ± 0.4, we estimated the limit of 
detection to be 5 µg/mL at three standard deviations above the mean of the background.  
To understand how biodegradation affects ultrasound signal we also imaged samples after 
different periods of dissolution in standard PBS (Fig. 6D). We found that the signal has a 
maximum near 10 minutes, but remains elevated at least 4 hours after wetting. 
Interestingly, the increase from 2 minutes to 10 minutes was significant (p<0.05) and 
suggests that the wetting of the PGNs may induce hydration that increases backscatter. 
The frequency of imaging is also an important parameter. Higher frequencies have better 
resolution, but lower depth of penetration and the echogencity of the material may change 
as a function of frequency. To understand how the PGNs behave at both clinical and pre-
clinical frequencies, we also imaged at 16 MHz (Fig. 6E). We measured the signal of a 1 
mg/mL sample of nanoparticles as well as the background signal of agar. We then plotted 
both the signal and signal-to-background (S/B) in Figure 6F. While the signal was 36% 
higher at 40 MHz, the signal-to-background at 16 MHz was 4.6-fold higher than 40 MHz 
because of a lower background signal. These data indicate that the PGNs are suitable for 
imaging at a variety of both clinical and pre-clinical frequencies. 
 In vivo and cellular ultrasound imaging 
To understand the capability of PGNs for in vivo imaging and biodegradation, we 
implanted 100 µL boluses of increasing concentrations of PGNs onto the rear flake of nude 
Page 8 
 
mice (Fig. 7A). These samples were in a 50% matrigel carrier and this vehicle served as 
the 0 mg/mL or negative control. Each implant was imaged at 40 MHz and the backscatter 
quantitated for various concentrations in Figure 7C. The calculated limit of detection in 
vivo is 9 µg/mL of PGNs—a value nearly two-fold higher than in vitro analysis. This is 
because of the increased background signal in in vivo imaging.  
We also studied the capability for in vivo biodegradation. Mice implanted with 2 mg/mL 
PGNs were imaged after implantation (Fig. 7A) and one day later (Fig. 7B). As expected, 
the matrigel and saline carriers were largely resorbed into circulation and extracellular 
matrix. Concurrently, the PGNs implanted began to degrade—we observed a 3.5-fold 
decrease in signal-to-background after one day (Fig. 7D). 
A final study labelled MSCs with the PGNs. We first optimized the labelling protocol 
using the cell fluorescence to monitor labelling. There was a linear relationship (R2=0.98) 
between the starting concentration and the resulting cell fluorescence from 30 to 1000 
µg/mL of PGNs at 2 hours of incubation. When the incubation time was optimized from 1 
to 360 minutes at 500 µg/mL, a marked plateau effect was noted after 1 hour of incubation. 
Further incubation with cells did not significantly increase cell signal (p>0.05). Even 30 
minutes of incubation gave cells signal that was 70% of maximum. We used these 
conditions to label MSCs and then imaged them with ultrasound (Fig. 8C) and 
fluorescence microscopy (Fig. 8D).  
We next used microscopy to understand the interaction of the PGNs with the MSC. 
Epifluorescence microscopy indicated low non-specific binding of PGNs to the culture 
flaks. Indeed, <5% of the fluorescent pixels do not correspond to a cell in Fig. 8E with 
many regions of increased signal throughout the MSC. 
Page 9 
 
We also used confocal microscopy to study the distribution of the PGNs. Our goal was to 
determine whether the nanoparticles were on the cells or inside the cells. This is important 
because nanoparticles that were only on the surface could become detached after implant 
and incorrectly be considered a cell. The confocal data in Figure 8K shows that the 
nanoparticles are indeed located throughout the cell in the cytoplasm and are not simply on 
the cell surface. 
Finally, we placed different numbers of cells in a 100 µL inclusion in an agar phantom and 
imaged at 40 MHz. We used this cell volume because it is similar to the injection volume 
used in trials of non-human primates and would likely be used in man. We noted a a linear 
relationship between the number of cells and the ultrasound backscatter (R2>0.99; Fig. 
8C), which is important for studies in which unknown numbers of cells may need to be 
quantitated. The calculated limit of detection for ultrasound imaging was 4000 MSCs at 
three standard deviations above the mean of the background.  
DISCUSSION  
In the present study, we take advantage of the sol-gel preparation method to synthesise 
controlled degradation materials and the subsequent utility of electrospraying to prepare 
ternary phosphate-based sol-gel derived glass nanospheres in the diameter size range of 
200-500 nm. One limitation of this approach is throughput versus “bottom-up” 
nanoparticles synthetic approaches, however we were able to produce 60 mg of 
nanoparticles per hour which is sufficient for imaging experiments. Previous approaches to 
preparing these glasses have been focused on preparing bulk sol-gel glasses. However, the 
slow sol-gel reaction and difficulty to make bulk glasses have limited their biomedical 
applications. In our work, faster reactive precursors and lower heat-treatment temperature 
were applied that allowed us to process these sol-gel derived glasses via electrospraying 
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and also incorporate fluorescein dye whilst processing (due to the relatively benign 
processing temperatures). 
The amorphous nature of these PGNs was confirmed by XRD analysis. The 31P NMR and 
FTIR results also show the structure of these PGNs consists of mainly Q1 and Q2 
phosphate units. These findings confirm the amorphous and glassy structure of the PGNs 
that are more desirable as a biodegradable material because they do not fragment during 
the degradation, which may cause inflammation.32    
The PGNs have strong ultrasound backscattering capabilities both in vivo and in vitro. 
Phantom experiments indicated a limit of detection of 5 µg/mL with linear behaviour 
below 1000 µg/mL (Fig. 6A). The imaging window of this material is below 4 hours. The 
ICP data show the highest rate of dissolution within the first 12 hours of immersion in 
distilled water (Fig. 4), and our time course study shows that by 4 hours the signal has 
decreased more than 2-fold with even further decreases the next day (Fig. 6D). This is 
particularly important because it bridges a gap between the minutes of stability of 
microbubbles and the months of stability of Stober silica particles.33, 34  
One potential concern is that the high local ionic concentrations could perturb cellular 
function. For 0.1 mg/mL of PGNs, over the 48 hours of dissolution study and assuming no 
diffusion, cells would be exposed to 41 ppm (PO4)3-, 32 ppm Ca2+, and 16 ppm Na+ (Fig. 
4). These values are well within the standard physiological range of serum chemistries 35. 
For example, the reference range of Ca2+ is 8.5-10 mg/dL or 85 – 100 ppm. The additional 
calcium due to the contrast agents is within the reference range and will not perturb cell 
metabolism. Furthermore, diffusion and normal circulation will equilibrate any locally 
disturbed ionic concentrations.  
To further confirm this, we performed a series of cell toxicity assays. While we did find 
that very high doses (1000 µg/mL) increased ROS (hydroxyl, peroxyl, etc.) activity within 
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the cell, this is much higher than the concentrations needed for imaging: 250 µg/mL for 
MSC imaging and >9 µg/mL for subcutaneous imaging (Fig. 5A). All materials—even 
water—are toxic at some concentration, our goal here was to discover what concentration 
began to dysregulates metabolism and work below that concentration. After PGNs 
implantation into animals, we noticed no changes in posture, behaviour, gait, or feeding 
with observation up to two weeks.  
We also used the MTS assay to study cell metabolism and viability via mitochondrial 
reductase activity (Fig. 5).  MTS is a colorimetric, water-soluble tetrazolium dye that 
indicates the activity of oxidoreductase enzymes. One concern was that the degradation 
products may increase the sodium, calcium, and phosphorus concentration to levels 
inconsistent with cell survival. Thus, it was important for us to study both fresh and 
degraded PGNs in this assay. Fortunately, we noticed no cytotoxicity in either sample 
group at concentrations below 500 µg/mL (Fig. 5). 
Although we did not investigate tumor imaging here, the PGNs implantation experiments 
(Fig. 7) indicated that concentrations down to 9 µg/mL could be imaged in vivo. This is 
important because nanoparticle contrast agents must overcome significant competition 
from the reticuloendothelial system to reach target tissue. Values near 4%ID/g are 
common for nanoparticle contrast agents. Thus, a 1 g tumor would need at least 225 µg of 
material injected into the 2.5 mL murine blood pool to achieve 4%ID/g accumulation. 
Importantly, this concentration is well below the concentration that increased ROS 
generation.  
Our primary goal was cell imaging, which is critical to understand the location of 
implanted stem cells in regenerative medicine. We achieved cell counting below 5000 cells 
in 100 µL volumes (Fig. 8). While we do not achieve the single cell counts possible with 
some MRI techniques,36 the cell counts described here are more than sufficient for clinical 
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trials that will likely use millions of cells,37 38, 39  These low detection limits would be 
useful because it would allow one to not label all cells in a given population. The 4 hour 
imaging window would be useful for imaging the immediate implantation event in cells.  
Long term imaging could utilize a reporter gene.40  
The detection limits reported here are higher than that achieved with perfluorocarbon 
microbubbles. Indeed, these can be detected even at the single microbubble level.41 The 
PGNs will definitely not be detectable at the single particle level, but did have detection 
levels down to 50 µg/mL, which is on par with the 20 µg/mL detection limits we have 
reported previously with silica nanoparticles.14  These materials also have lower overall 
signal intensity than perfluorocarbon microbubbles. However, perfluorocarbon 
microbubbles are approximately the same size as cells and using them for ultrasound cell 
imaging is difficult. Importantly, the PGNs are approximately 10-fold smaller in diameter 
(and 1000-fold smaller in volume) and thus have a significant advantage for ultrasound 
cell imaging. Also, the time stability of the PGNs (~4 hours), is much longer than the 
minutes of in vivo stability for perfluorocarbon microbubbles. 
CONCLUSION 
In this study, for the first time, according to the authors knowledge, ternary phosphate-
based sol-gel glass nanospheres in the diameter size range of 200-500 nm has been 
successfully prepared. The amorphous and glassy nature of these PGNs was confirmed via 
XRD, 31P NMR, and FTIR analysis. This probe is useful for both in vivo and in vitro 
ultrasound imaging and has utility for cell tracking applications in regenerative medicine. 
Future work may utilize these contrast agents for tasks beyond regenerative medicine 
including targeted tumor imaging after i.v injection and tumor imaging. 
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MATERIALS AND METHODS 
Synthesis of the sol for subsequent electrospraying 
The following chemical precursors were used without further purification: triethyl 
phosphate (Aldrich, 99%), calcium methoxyethoxide (Ca-methoxyethoxide, ABCR, 20% 
in methoxyethanol), sodium methoxide solution (NaOMe, Aldrich, 30 wt% in methanol), 
2-methoxyethanol (MeO-EtOH, Aldrich, 99.8%), n-dimethyl formamide (nDMF, Alfa-
Aesar, 99.8%), acetone (Alfa-Aesar, 99.5%), fluorescein (Aldrich), and silicone oil 
(Aldrich). 
The sol-gel synthesis was started by diluting triethyl phosphate in MeO-EtOH at a molar 
ratio of 1:3 and allowing them to react for about 10 minutes while it was magnetically 
stirring (the whole reaction being carried out in a dried vessel). The vessel was then cooled 
in an ice-bath before adding Ca-methoxyethoxide and NaOMe dropwise to the vessel. 
Finally, in the last stage n-DMF (a molar ratio of 0.25:1) was added to the solution and a 
homogeneous solution was obtained after 10 min of stirring. For labelling experiments, 1 
wt% fluorescein dye was incorporated to a subset of the mixture. 
Electrospraying 
The mixtures were aged overnight at 60 °C before being electrosprayed over the heated 
silicone oil. The electrospraying technique used a stainless steel capillary tube (18 gauge), 
syringe pump, high voltage source, and silicone oil as a substrate. The distance between 
the nozzle and substrate was 10 cm and the temperature of the substrate was controlled and 
kept at 150 °C. The flow rate was 0.20 mL h-1 and high voltage of 20 kV was applied 
between the nozzle and the ground. The particles were separated from silicone oil via 
centrifugation at 4600 rpm for 30 min. The collected particles were washed three times 
with acetone and then dried at 180 °C for 2 h to evaporate the acetone and other remaining 
solvents. 
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Characterization 
SEM and EDX 
SEM images were obtained on a Philips-XL30 instrument (Philips, Netherland) at an 
accelerating voltage of 5 kV and working distance of 10 mm. The PGNs were mounted 
onto a stub using araldite and sputter-coated with gold alloys. The diameter was measured 
for more than 100 particles using Image-pro plus software (Media Cybernetics, USA). To 
determine the exact composition of the PGNs, EDX-Inca 300 (Oxford instrument, UK) 
was used. Scanning electron microscopy (SEM)- XL30 was operated at 20 kV, spot size 5, 
and working distance of 10 mm to identify the particular elements and their relative 
proportions from the scanned area. 
XRD and 31P MAS-NMR 
The XRD on PGNs was obtained on a Bruker-D8 Advance Diffractometer (Brüker, UK) in 
a flat plate geometry using Ni filtered Cu Kα radiation. Data were collected using a Lynx 
Eye detector with a step size of 0.02˚ over an angular range of 2Ɵ=10-100˚ and a count 
time of 12 sec. 
The solid state 31P MAS-NMR spectrum was recorded at 161.87 MHz using a Varian 
VNMRS-400 spectrometer. The sample was loaded into a 4 mm (rotor o.d.) magic angle 
spinning probe and the spectrum was obtained using direct excitation (with a 90° pulse) 
with a 60 sec recycle delay at ambient probe temperature (~25 °C) at a sample spin rate of 
10 kHz and between 20 and 88 repetitions were accumulated. The deconvolution of the 
spectrum was carried out using DMFit software and was referenced to the resonance of the 
ammonium dihydrogen phosphate (NH4H2PO4) at 0.9 ppm (relative to 85% H3PO4 
solution at 0 ppm).42   
FTIR 
Page 15 
 
The FTIR spectrum of PGNs was collected using a Perkin Elmer spectrometer 2000 
(USA). The sample was scanned at room temperature in the absorbance mode in the range 
1500-600 cm-1 and the data were analysed by Perkin Elmer software. 
Tissue Culture, Labelling, and Cytotoxicity  
Mesenchymal stem cells (MSCs) and culture media were purchased from Lonza (p/n 2501 
and 3001, respectively). Cells were seeded at 5000 cells/cm2, and the media was changed 
every 2-3 days. Cell labeling used MSCs plated at 5000 cells/cm2 in a 225 cm2 flask and 
grown to 80% confluence. For labeling optimization studies we used 12 well plates and the 
same seeding density. The day of labeling, we prepared the PGN contrast agent in PBS at 
25 mg/mL. For optimizing the labeling experiments, decreasing volumes of this sample 
were then added to MSCs in media. The cells were exposed to PGN concentrations of 30 – 
1000 µg/mL in the media; the NPs were then incubated with the cells for 2 hours and then 
washed thrice with PBS. To study the effect of time, we used 500 µg/mL of PGNs from 1 
– 360 minutes. For labelling experiments, we used fluorescently-tagged PGNs. Cell 
fluorescence was measured with a plate reader (Bio-TEK), and fluorescence microscopy 
used a EVOS Fl (Invitrogen). Confocal microscopy used a Leica confocal microscope 
(TCS SP5) with a 20x APO objective (p/n 506147) seated on a Virbraplane air table. For 
z-stacking experiments, 20 slices were collected over ~ 50 µm. Video was made by 
compiling the individual TIFF files into an .avi file.  
For the cell counting experiments, we used the optimized protocol of 2 hours and 250 
µg/mL. After labeling, the cells were washed three times with saline. We monitored the 
washes with absorbance spectroscopy to confirm that the third wash containined no more 
nanoparticles. The cells were then removed from the flask with TrypLE Express 
(Invitrogen), washed with complete media to deactivate the trypsin, centrifuged at 300g at 
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4 oC for 5 minutes and resuspended in saline. The cells were counted with an automated 
hemocytometer before being placed in a phantom and imaged. 
For cell viability, cells were plated in a 96 well plate and allowed to adhere overnight. The 
next day, increasing concentrations of PGNs were added and allowed to incubate for 4 
hours. For a positive control, we added 10 µL of 1 mg/mL cetyl trimethylammonium 
bromide (CTAB) in phosphate buffered saline. We assessed cell viability using the 
tetrazolium-based metabolic reagent compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-(4-sulfophenyl) -2H-tetrazolium (MTS; Promega). The solution 
was used as received—20 µL of MTS solution was added to each well in a 96 well plate 
containing cells and allowed to incubate for 3 hours. Absorbance at 490 nm was measured 
to estimate cell viability. Each condition was tested with at least four replicates. 
To determine whether the particles generated any reactive oxygen species, we utilized 
2’,7’ –dichlorofluorescin diacetate (DCFDA; Biotium). We first made a 1 mg/mL working 
solution of DCFDA in dimethyl sulfoxide and then diluted 125 µL of the DMSO solution 
to 10 mL of Hanks Buffered Saline Solution (HBSS). Cells were washed with fresh HBSS 
and then 100 µL of the DCFDA solution in HBSS was added; the plate was incubated at 
37 oC for 1 hour. Next, the labelling solution was aspirated and the cells again washed with 
fresh HBSS. Increasing concentrations of particles in 100 µL were then added. Controls 
include 10% H2O2 and wells with no cells. The fluorescence of each well was measured 1 
hour later. 
Biodegradation Monitoring 
Biodegradation was monitored via inductively coupled plasma mass spectroscopy (ICP-
MS). The experiment used 0.1 mg/mL samples in deionized water at 37 °C with three 
replicates at the following time points: 0, 0.2, 0.5, 1, 3, 6, 12, 24, and 48 hours.  The tubes 
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were secured to a tube rotation device set to 5 rotations per minute. This device was in a 37 
°C incubator under ambient humidity. After each time point, the resulting suspension was 
centrifuged at 4600 rpm for 30 min to separate the PGNs from the solution. The liquid 
phase was then extracted and the PGNs were dried in the oven at 60 °C before they were 
resuspended in fresh deionized water. The release of calcium, phosphorus, and sodium in 
solution was measured by using a Spectro Mass 2000 Analytical System calibrated across 
the predicted concentrations range 0 ppb – 4000 ppb by dilution of 100 ppm elemental 
standards. Calcium standard was obtained as part of a pre-made standard solution (Fluka) 
whereas phosphorus and sodium standards were created from analytical grade K2HPO4 
(Sigma) and NaNO3 (Sigma) salts respectively. Standards were first diluted in deionized 
water to result in the desired concentration range. Both samples and standards were diluted 
in 1:1 in 4% HNO3 (Fluka) and analysed in reference to a blank (2% HNO3) solution under 
standard operating conditions (Power: 1350 W; Coolant Flow: 15 L/min: Auxiliary Flow: 
1 L/min). Results were expressed as a cumulative ion release over the full period of the 
degradation study. 
In vitro ultrasound imaging 
To measure the echogenicity of the nanoparticles, we placed increasing concentrations in a 
1% agarose phantom. Ultrasound backscatter mode (B-mode) images were collected with 
a Visualsonics 2100 scanner with a MS-550 transducer (Fuji) for 40 MHz centre frequency 
imaging or a MS-250 transducer for 16 MHz. Other imaging parameters included 100% 
power, 35 dB gain and a 60 dB dynamic range. At least three frames were collected for 
each sample and saved as TIFF files and were quantitated with ImageJ software using 
region of interest analysis and 8-bit depth as the the dependant variable (0-255) 43. To 
calculate the limit of detection, we used three standard deviations above the mean of the 
blank. 
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In vivo ultrasound imaging 
All animal studies were approved by the Administrative Panel for Laboratory Animal Care 
(IACUC) at Stanford University. Nude mice aged 10-14 weeks were anaesthetized with 
2% isofluorane in oxygen at 2 L/min. The PGNs were dissolved in 50:50 matrigel:PBS at 
2.0, 0.25, and 0.1 mg/mL. The injection volume was 100 µL that was subcutaneously 
implanted on the rear flank of the mice. The animals were imaged 10 minutes after 
implantation after the matrigel had solidified using 40 MHz centre frequency, 100% 
power, 35 dB gain, and a 60 dB dynamic range. At least three frames were collected for 
each sample and saved as TIFF files and images were quantitated with ImageJ. For 
longitudinal imaging the injection site was marked and the animal returned to the same 
position the next day for identical imaging conditions.  
  
Page 19 
 
ACKNOWLEDGEMENTS 
JVJ acknowledges support from NHLBI (K99-HL117048) and the Burroughs Wellcome 
Fund (1011172). Instrumentation used in this work was supported by NIH grant S10-
OD010344. This work was supported in part by the Priority Research Centers Program (No. 
2009-0093829) through the National Research Foundation, Republic of Korea. The authors 
would like to thank to the EPSRC NMR Service at Chemistry Department- Durham 
University for the MAS NMR measurement.  
	  
REFERENCES 
1. Goldberg, B. B.; Liu, J. B. Contrast Agents in Abdominal Ultrasound. Front Gastroint 
Res 1997, 24, 323-341. 
2. Benchimol, M. J.; Hsu, M. J.; Schutt, C. E.; Hall, D. J.; Mattrey, R. F.; Esener, S. C. 
Phospholipid/Carbocyanine Dye-Shelled Microbubbles as Ultrasound-Modulated Fluorescent 
Contrast Agents. Soft Matter 2013, 9, 2384-2388. 
3. Nakatsuka, M. A.; Hsu, M. J.; Esener, S. C.; Cha, J. N.; Goodwin, A. P. DNA-Coated 
Microbubbles with Biochemically Tunable Ultrasound Contrast Activity. Adv. Mater. 2011, 
23, 4908-4912. 
4. Willmann, J. K.; Paulmurugan, R.; Chen, K.; Gheysens, O.; Rodriguez-Porcel, M.; 
Lutz, A. M.; Chen, I. Y.; Chen, X.; Gambhir, S. S. Us Imaging of Tumor Angiogenesis with 
Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice. 
Radiology 2008, 246, 508-518. 
5. Gramiak R; Shah PM. Echocardiography of the Aortic Root. Invest Radiol 1968, 3, 
356-366. 
6. Klibanov, A. L. Targeted Delivery of Gas-Filled Microspheres, Contrast Agents for 
Ultrasound Imaging. Advanced Drug Delivery Reviews 1999, 37, 139-157. 
7. Schutt, E. G.; Klein, D. H.; Mattrey, R. M.; Riess, J. G. Injectable Microbubbles as 
Contrast Agents for Diagnostic Ultrasound Imaging: The Key Role of Perfluorochemicals. 
Angew Chem Int Edit 2003, 42, 3218-3235. 
8. Kono, Y.; Holscher, T.; Mattrey, R. F. Use of Ultrasound Microbubbles for Vascular 
Imaging. Fund Biomed Technol 2008, 311-325. 
9. Klibanov, A. L. Ligand-Carrying Gas-Filled Microbubbles: Ultrasound Contrast 
Agents for Targeted Molecular Imaging. Bioconjugate Chem 2005, 16, 9-17. 
10. Xing, Z. W.; Wang, J. R.; Ke, H. T.; Zhao, B.; Yue, X. L.; Dai, Z. F.; Liu, J. B. The 
Fabrication of Novel Nanobubble Ultrasound Contrast Agent for Potential Tumor Imaging. 
Nanotechnology 2010, 21. 
11. Shapiro, M. G.; Goodwill, P. W.; Neogy, A.; Yin, M.; Foster, F. S.; Schaffer, D. V.; 
Conolly, S. M. Biogenic Gas Nanostructures as Ultrasonic Molecular Reporters. Nat 
Nanotechnol 2014, 9, 311-316. 
12. Krupka, T. M.; Solorio, L.; Wilson, R. E.; Wu, H. P.; Azar, N.; Exner, A. A. 
Formulation and Characterization of Echogenic Lipid-Pluronic Nanobubbles. Mol 
Pharmaceut 2010, 7, 49-59. 
Page 20 
 
13. Casciaro, S.; Conversano, F.; Ragusa, A.; Malvindi, M. A.; Franchini, R.; Greco, A.; 
Pellegrino, T.; Gigli, G. Optimal Enhancement Configuration of Silica Nanoparticles for 
Ultrasound Imaging and Automatic Detection at Conventional Diagnostic Frequencies. Invest 
Radiol 2010, 45, 715-724. 
14. Jokerst, J. V.; Khademi, C.; Gambhir, S. S. Intracellular Aggregation of Multimodal 
Silica Nanoparticles for Ultrasound-Guided Stem Cell Implantation. Sci Transl Med 2013, 5. 
15. Liberman, A.; Wu, Z.; Barback, C. V.; Viveros, R.; Blair, S. L.; Ellies, L. G.; Vera, D. 
R.; Mattrey, R. F.; Kummel, A. C.; Trogler, W. C. Color Doppler Ultrasound and Gamma 
Imaging of Intratumorally Injected 500 Nm Iron-Silica Nanoshells. Acs Nano 2013, 7, 6367-
6377. 
16. Ta, C. N.; Liberman, A.; Martinez, H. P.; Barback, C. V.; Mattrey, R. F.; Blair, S. L.; 
Trogler, W. C.; Kummel, A. C.; Wu, Z. Integrated Processing of Contrast Pulse Sequencing 
Ultrasound Imaging for Enhanced Active Contrast of Hollow Gas Filled Silica Nanoshells 
and Microshells. J Vac Sci Technol B 2012, 30. 
17. Martinez, H. P.; Kono, Y.; Blair, S. L.; Sandoval, S.; Wang-Rodriguez, J.; Mattrey, R. 
F.; Kummel, A. C.; Trogler, W. C. Hard Shell Gas-Filled Contrast Enhancement Particles for 
Colour Doppler Ultrasound Imaging of Tumors. Medchemcomm 2010, 1, 266-270. 
18. Malvindi, M. A.; Greco, A.; Conversano, F.; Figuerola, A.; Corti, M.; Bonora, M.; 
Lascialfari, A.; Doumari, H. A.; Moscardini, M.; Cingolani, R., et al. Magnetic/Silica 
Nanocomposites as Dual-Mode Contrast Agents for Combined Magnetic Resonance Imaging 
and Ultrasonography. Adv Funct Mater 2011, 21, 2548-2555. 
19. Knowles, J. C. Phosphate Based Glasses for Biomedical Applications. Journal of 
Materials Chemistry 2003, 13, 2395. 
20. Hench, L. L.; Polak, J. M. Third-Generation Biomedical Materials. Science 2002, 295, 
1014-+. 
21. Franks, K.; Abrahams, I.; Georgiou, G.; Knowles, J. C. Investigation of Thermal 
Parameters and Crystallisation in a Ternary Cao-Na(2)O-P(2)O(5)-Based Glass System. 
Biomaterials 2001, 22, 497-501. 
22. Pickup, D. M.; Guerry, P.; Moss, R. M.; Knowles, J. C.; Smith, M. E.; Newport, R. J. 
New Sol–Gel Synthesis of a (Cao)0.3(Na2o)0.2(P2o5)0.5 Bioresorbable Glass and Its 
Structural Characterisation. Journal of Materials Chemistry 2007, 17, 4777. 
23. Lee, I. H.; Foroutan, F.; Lakhkar, N. J.; Gong, M. S.; Knowles, J. C. Sol-Gel 
Synthesis and Structural Characterization of P2o5-Cao-Na2o Glasses. Phys. Chem. Glasses-
Eur. J. Glass Sci. Technol. Part B 2013, 54, 115-120. 
24. Carta, D.; Knowles, J. C.; Smith, M. E.; Newport, R. J. Synthesis and Structural 
Characterization of P(2)O(5)-Cao-Na(2)O Sol-Gel Materials. J. Non-Cryst. Solids 2007, 353, 
1141-1149. 
25. Baia, L.; Muresan, D.; Baia, M.; Popp, J.; Simon, S. Structural Properties of Silver 
Nanoclusters-Phosphate Glass Composites. Vibrational Spectroscopy 2007, 43, 313-318. 
26. Byun, J. O.; Kim, B. H.; Hong, K. S.; Jung, H. J.; Lee, S. W.; Izyneev, A. A. 
Properties and Structure of Ro-Na2o-Al2o3-P2o5 (R=Mg, Ca, Sr, Ba) Glasses. J. Non-Cryst. 
Solids 1995, 190, 288-295. 
27. Ilieva, D.; Jivov, B.; Kovacheva, D.; Tsacheva, T.; Dimitriev, Y.; Bogachev, G.; 
Petkov, C. Ft-Ir and Raman Spectra of Gd Phosphate Crystals and Glasses. J. Non-Cryst. 
Solids 2001, 293, 562-568. 
28. Moustafa, Y. M.; El-Egili, K. Infrared Spectra of Sodium Phosphate Glasses. Journal 
of Non-Crystalline Solids 1998, 240, 144-153. 
29. Sene, F. F.; Martinelli, J. R.; Gomes, L. Synthesis and Characterization of Niobium 
Phosphate Glasses Containing Barium and Potassium. J. Non-Cryst. Solids 2004, 348, 30-37. 
Page 21 
 
30. Bunker, B. C.; Arnold, G. W.; Wilder, J. A. Phosphate-Glass Dissolution in Aqueous-
Solutions. Journal of Non-Crystalline Solids 1984, 64, 291-316. 
31. Hare, J. M.; Fishman, J. E.; Gerstenblith, G.; Velazquez, D. L. D.; Zambrano, J. P.; 
Suncion, V. Y.; Tracy, M.; Ghersin, E.; Johnston, P. V.; Brinker, J. A., et al. Comparison of 
Allogeneic Vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by 
Transendocardial Injection in Patients with Ischemic Cardiomyopathy the Poseidon 
Randomized Trial. Jama-J Am Med Assoc 2012, 308, 2369-2379. 
32. Bostman, O. M.; Pihlajamaki, H. K. Adverse Tissue Reactions to Bioabsorbable 
Fixation Devices. Clin Orthop Relat R 2000, 216-227. 
33. Hudson, S. P.; Padera, R. F.; Langer, R.; Kohane, D. S. The Biocompatibility of 
Mesoporous Silicates. Biomaterials 2008, 29, 4045-4055. 
34. He, Q. J.; Zhang, Z. W.; Gao, F.; Li, Y. P.; Shi, J. L. In Vivo Biodistribution and 
Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and 
Pegylation. Small 2011, 7, 271-280. 
35. Bishop, M. L. Clinical Chemistry. 6th ed.; 2010. 
36. Shapiro, E. M.; Sharer, K.; Skrtic, S.; Koretsky, A. P. In Vivo Detection of Single 
Cells by Mri. Magn Reson Med 2006, 55, 242-249. 
37. Chong, J. J. H.; Yang, X. L.; Don, C. W.; Minami, E.; Liu, Y. W.; Weyers, J. J.; 
Mahoney, W. M.; Van Biber, B.; Cook, S. M.; Palpant, N. J., et al. Human Embryonic-Stem-
Cell-Derived Cardiomyocytesregenerate Non-Humanprimate Hearts. Nature 2014, 510, 273-
+. 
38. Hare, J.; Fishman, J.; Gerstenblith, G. The Poseidon Randomized Trial. JAMA 2012, 
308, 2369-2379. 
39. Makkar, R. R.; Smith, R. R.; Cheng, K.; Malliaras, K.; Thomson, L. E.; Berman, D.; 
Czer, L. S.; Marbán, L.; Mendizabal, A.; Johnston, P. V. Intracoronary Cardiosphere-Derived 
Cells for Heart Regeneration after Myocardial Infarction (Caduceus): A Prospective, 
Randomised Phase 1 Trial. The Lancet 2012, 379, 895-904. 
40. Yaghoubi, S. S.; Couto, M. A.; Chen, C.-C.; Polavaram, L.; Cui, G.; Sen, L.; 
Gambhir, S. S. Preclinical Safety Evaluation of 18f-Fhbg: A Pet Reporter Probe for Imaging 
Herpes Simplex Virus Type 1 Thymidine Kinase (Hsv1-Tk) or Mutant Hsv1-Sr39tk's 
Expression. J. Nucl. Med. 2006, 47, 706-715. 
41. Klibanov, A. L.; Rasche, P. T.; Hughes, M. S.; Wojdyla, J. K.; Galen, K. P.; Wible, J. 
H.; Brandenburger, G. H. Detection of Individual Microbubbles of Ultrasound Contrast 
Agents - Imaging of Free-Floating and Targeted Bubbles. Invest Radiol 2004, 39, 187-195. 
42. Massiot, D.; Fayon, F.; Capron, M.; King, I.; Le Calv�, S. p.; Alonso, B.; Durand, J.-
O.; Bujoli, B.; Gan, Z.; Hoatson, G. Modelling One- and Two-Dimensional Solid-State Nmr 
Spectra. Magn. Reson. Chem. 2002, 40, 70-76. 
43. Schneider, C. A.; Rasband, W. S.; Eliceiri, K. W. Nih Image to Imagej: 25 Years of 
Image Analysis. Nat Methods 2012, 9, 671-675. 
	  
	  
	  
	  
	  
	  
Page 22 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
	  
	  
	  
Composition	  (mol%)	   P2O5	  	   CaO	  	   Na2O	  	  
(P2O5)	  55-­‐(CaO)	  30-­‐(Na2O)	  15	   55.0(42.5±1.0)	   30.0	  (37.9±0.9)	   15.0	  (19.6±0.8)	  
Table 1. Intended compositions and measured values determined by EDX (in brackets).  
Figure 1. (A) Schematic of the electrospraying setup. The high voltage between the nozzle and the ground 
created nanospheres that flew toward the heated silicone oil as a substrate to obtain dried gel nanospheres. 
SEM image of (B) washed and heat-treated PGNs (the scale bar is 2 µm) and (C) dispersed PGNs in ethanol 
solution after heat-treatment (the scale bar is 5 µm). The PGNs have an approximate size range of between 
200-500 nm with mean diameter size of 320 nm (N=100 particles). 
Figure 2. (A) XRD pattern of the PGNs indicate that it is free from any detectable crystalline phase and (B) 
31P NMR spectrum (black line) and the fitting (red line) that correspond to mainly Q1 and Q2 phosphate units. 
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Position	  (ppm)	  
(±1.0)	  	  	  	  	  	  	  	  	  	  	  
Qi	  
species	  
Line	  width	  (ppm)	  
(±2.0)	  
Abundance	  (%)	  
(±1.0)	  
1.7	  
-­‐8.3	  
-­‐21.9	  
0	  
1	  
2	  
6.7	  
10.1	  
12.5	  
1.9	  
59.5	  
38.6	  
Table 2. The 31P NMR peak parameters of the PGNs. 
 
Figure 3. FTIR spectrum and band assignment for PGNs (ʋ, stretching; s, symmetric; 
as, asymmetric; δ, deformation) 
Figure 4. Cumulative release of phosphorus, calcium, and sodium in deionized water as a function of 
time for the investigated PGNs.  Error bars represent the standard deviation of 3 samples. 
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Figure 5. Cytotoxicty data. Increasing concentrations of PGNs were used to label MSCs for 4 hours followed 
by treatment with different markers of cytotoxicity. All experiments were validated with a positive control 
(POS). A) Cells were plated, tagged with DCHCF, and then perturbed with PGNs. Any ROS generation resulted 
in fluorescence from the DCHCF probe. Only the 1000 µg/mL sample significantly upregulated ROS. A 
hydrogen peroxide positive control validated the assay. The negative control was wells with no cells. B) The 
MTS reagent measures cell metabolism and showed no decrease at any concentration studied. Here, we used 
both freshly dissolved PGNs (Fresh) and PGNs that had been in solution for 24 hours (Degraded). No 
concentration decreased metabolism. Error bars represent the standard deviation of 6 wells. 
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Figure 6. Ultrasound Signal Performance of the PGNs. Ultrasound images in the z-axis for inclusions with 0 
mg/mL PGNs (A) and 1 mg/mL PGNs at 40 MHz (B). The increased backscatter results from increasing number 
of particles that was further quantitated for multiple fields of view in (C). PGNs (0.25 mg/mL) at various time 
points were imaged with ultrasound to understand how signal changes as a function of time (D).  
These data indicate that ultrasound signal decreases as the nanoparticle degrades because of decreased acoustic 
impedance. The imaging window is within the first four hours of dissolution. Panel E is an ultrasound image in 
the z-axis for 1 mg/mL PGNs at 16 MHz, and F is signal and signal-to-background for both 16 and 40 MHz. 
Here, signal was defined as echogenicity of the sample and background was adjacent agar. While the signal was 
higher at 40 MHz, the signal-to-background at 16 MHz was 4.6-fold higher than 40 MHz because of a lower 
background signal. These data indicate that the PGNs are suitable for imaging at both clinical and pre-clinical 
frequencies.  
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Figure 7. In vivo imaging with PGNs. Nu/nu mice received 100 µL boluses of 2 mg/mL PGNs in 1:1 
matrigel:PBS and imaged at 40 MHz immediately after (A) and 1 day after (B). Red outlines in A and B indicate 
the region of implantation and the scale bar and intensity bar in A apply to both panels. (C) Decreasing 
concentrations of PGNs were also implanted to calculate the limit of detection and variance between animals. 
Error bars represent the standard error of measurement. (D) Changes in ultrasound backscatter for PGNs 
indicates a 3.5-fold decrease in signal-to-background ratio (SBR). Error bars represent the standard deviation.  
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Figure 8. PGNs label MSCs. The optimal labeling conditions were tested empirically including starting 
concentration of PGNs (A) and incubation time (B). We found a nearly linear relationship between starting 
concentration and cell fluorescence (A). These concentrations used 2 hours of labeling. In B, we studied the 
effect of time and found that incubation times beyond 2 hours offered no additional signal. (C) MSCs labelled 
with these conditions (500 µg/mL and 2 hours) were imaged with 40 MHz ultrasound—the limit of detection is 
4000 MSCs. Phase contrast/fluorescence microscopy of naive MSCs (D) and MSCs labeled with PGNs shows 
that fluorescence only corresponds to the cells (low non-specific binding) (E). Panel F is ultrasound image of 
agarose phantom only (no cells), panel G is the ultrasound backscatter from 225,000 MSCs, and panel H is the 
same number MSCs labeled with PGNs in an agar phantom. The PGNs increased the backscatter two-fold 
versus unlabeled cells. Panel K is a confocal image through the medial slice of adherent cells labelled with 
fluorescently tagged PGNs. The image shows that the nanoparticles are located throughout the cell and are 
localized in the cytoplasm and are not simply on the cell surface.	  
